Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $39.5000 (3.95%) ($37.2000 - $40.5000) on Fri. Dec. 4, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.8% (three month average) | RSI | 52 | Latest Price | $39.5000(3.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -0.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) SKYY(8%) ARKK(7%) PEJ(7%) VT(7%) XLF(7%) | Factors Impacting CAPR price | CAPR will decline at least -1.9% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-3%) VCIT(-2%) SLV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.9% (StdDev 3.8%) | Hourly BBV | 0 () | Intraday Trend | 3.9% | | | |
|
Resistance Level | $40.84 | 5 Day Moving Average | $39.7(-0.5%) | 10 Day Moving Average | $41.05(-3.78%) | 20 Day Moving Average | $40.84(-3.28%) | To recent high | -15.4% | To recent low | 3.9% | Market Cap | $778m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |